Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

被引：42
|
作者：
Uppendahl, Locke D. [1 ]
Dahl, Carly M. [2 ]
Miller, Jeffrey S. [3 ]
Felices, Martin [3 ]
Geller, Melissa A. [1 ]
机构：
[1] Univ Minnesota, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 8卷
关键词：
natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer; TUMOR-INFILTRATING LYMPHOCYTES; APOPTOSIS-INDUCING LIGAND; OVARIAN-CANCER PATIENTS; CLASS-I MOLECULES; ANTI-CD20; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD LYMPHOCYTES; IFN-GAMMA PRODUCTION; UTERINE NK CELLS; ACTIVATING RECEPTOR; ADOPTIVE TRANSFER;
D O I：
10.3389/fimmu.2017.01825
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] New directions in natural killer cell-based immunotherapy of human cancer
    Farag, SS
    Fehniger, TA
    Becknell, B
    Blaser, BW
    Caligiuri, MA
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (02) : 237 - 250
  • [22] Natural killer cell-based therapies in neuroblastoma
    Ghasempour, Abtin
    Mohseni, Rashin
    Sharif, Pouya Mahdavi
    Hamidieh, Amir Ali
    CELLULAR IMMUNOLOGY, 2025, 407
  • [23] Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas
    Kaur, Kawaljit
    Sanghu, Jashan
    Memarzadeh, Sanaz
    Jewett, Anahid
    VACCINES, 2024, 12 (06)
  • [24] Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy
    Kumar, N.
    Khakoo, S. I.
    HLA, 2018, 92 (01) : 3 - 11
  • [25] Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
    Joshi, Shweta
    Sharabi, Andrew
    PHARMACOLOGY & THERAPEUTICS, 2022, 235
  • [26] Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
    Nersesian, Sarah
    Glazebrook, Haley
    Toulany, Jay
    Grantham, Stephanie R.
    Boudreau, Jeanette E.
    FRONTIERS IN IMMUNOLOGY, 2019, 10 : 1782
  • [27] A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy
    McLellan, Alexander D.
    ONCOIMMUNOLOGY, 2014, 3 (04):
  • [28] Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors
    Quamine, Aicha E.
    Olsen, Mallery R.
    Cho, Monica M.
    Capitini, Christian M.
    CANCERS, 2021, 13 (11)
  • [29] Infusion reactions in natural killer cell immunotherapy: a retrospective review
    Mamo, Tewodros
    Williams, Shelly M.
    Kinney, Stephanie
    Tessier, Katelyn M.
    DeFor, Todd E.
    Cooley, Sarah
    Miller, Jeffrey S.
    McKenna, David H.
    CYTOTHERAPY, 2021, 23 (07) : 627 - 634
  • [30] Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
    Liu, Pingyi
    Chen, Lingling
    Zhang, Haiyan
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
12345